House dust mite immunotherapy in adults with allergic asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com


Medscape

House dust mite immunotherapy in adults with allergic asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
Taking house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablets in addition to maintenance medications appears to help reduce the risk of an attack in people with HDM allergy–related asthma. The double-blind, randomized study was …
HDM SLIT tablet can reduce risk of moderate or severe asthma exacerbationNews-Medical.net
Sublingual Immunotherapy Improves Dust Mite AllergyMedscape

all 6 news articles »

View full post on asthma – Google News

FDA approves reslizumab to treat severe asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com


Medscape

FDA approves reslizumab to treat severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
FDA has cleared reslizumab (Cinqair—Teva) for use with other asthma medicines for the maintenance treatment of severe asthma in adults. The drug is indicated for patients with a history of severe asthma attacks despite using their current asthma …
FDA approves Cinqair to treat severe asthmaFDA.gov
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
FDA Approves Teva's Asthma Injection to Treat Severe AsthmaNews Every day
Globes –UPI.com
all 55 news articles »

View full post on asthma – Google News

Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years – Pharmacy Today, American Pharmacists Association, pharmacist.com


JAMA: The Journal of the American Medical Association

Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years
Pharmacy Today, American Pharmacists Association, pharmacist.com
Lack of vitamin D during pregnancy can lead to breathing disorders early in a child's life. Researchers tested whether prenatal vitamin D supplementation could prevent asthma or recurrent wheezing by administering specific doses to 876 women aged …
Prenatal Vitamin D and Baby's Asthma RiskWebMD
Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The JAMA: The Journal of the American Medical Association
Lower Asthma Risk From Prenatal Vitamin D Unconfirmed But Supplement Isn't a Bad Idea: ExpertsLatinos Health
EurekAlert (press release)
all 30 news articles »

View full post on asthma – Google News

New treatment for severe asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com

New treatment for severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
In early November, FDA approved mepolizumab (Nucala—GlaxoSmithKline), a novel treatment for severe asthma. This new treatment is an interleukin-5 (IL-5) antagonist that works by inhibiting IL-5 signaling, with subsequent reduction in the production

View full post on asthma – Google News

Independent group says new Glaxo asthma drug far too expensive – Pharmacy Today, American Pharmacists Association, pharmacist.com

Independent group says new Glaxo asthma drug far too expensive
Pharmacy Today, American Pharmacists Association, pharmacist.com
The nonprofit analyzed the once-monthly injectable drug for severe asthma, finding that it should be priced at $7,800 to $12,000 a year, compared with the current list price of $32,500 a year. While the drug significantly reduces asthma attacks and

View full post on asthma – Google News

FDA advisers recommend approval of asthma drug for adults – Pharmacy Today, American Pharmacists Association, pharmacist.com

FDA advisers recommend approval of asthma drug for adults
Pharmacy Today, American Pharmacists Association, pharmacist.com
An FDA advisory committee has recommended the agency approve Teva Pharmaceutical's experimental drug reslizumab for severe asthma in patients aged 18 years and older. Reslizumab is an antibody drug designed to be given intravenously once every …

View full post on asthma – Google News

Study compares LRTAs with placebo for the treatment of asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com

Study compares LRTAs with placebo for the treatment of asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
Researchers conducted a systematic review and meta-analysis to compare leukotriene-receptor antagonists (LTRAs) with placebo in patients with mild asthma. The review, funded by NIH, included 50 randomized trials conducted through June 2015.

View full post on asthma – Google News

Study compares combination treatments for African-American adults with asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com


JAMA: The Journal of the American Medical Association

Study compares combination treatments for African-American adults with asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
The primary outcome was time to asthma exacerbation that required oral or parenteral corticosteroids. The results showed no difference between LABA plus ICS compared with tiotropium plus ICS in the primary outcome. There were also no significant …
LABAs, tiotropium perform similarly in black patients with asthmaClinical Advisor
Anticholinergic vs Long-Acting ?-Agonist in Combination With Inhaled JAMA: The Journal of the American Medical Association
Study Compares Combination Treatments for Black Adults with AsthmaHealthCanal.com (press release) (blog)
Doctors Lounge
all 5 news articles »

View full post on asthma – Google News

Leukotriene antagonists for first-line or add-on asthma therapy – American Pharmacists Association, pharmacist.com

Leukotriene antagonists for first-line or add-on asthma therapy
American Pharmacists Association, pharmacist.com
Key point: In patients with asthma, leukotriene-receptor antagonists (LTRAs) managed the disease just as successfully as inhaled glucocorticoid for first-line therapy or long-acting beta-2 agonist as add-on therapy. Finer points: Two parallel,

View full post on asthma – Google News